Evaluación de la terapia con anticuerpos monoclonares en pacientes con Eslerosis Múltiple.

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system, whose management has significantly evolved with the use of monoclonal antibodies (mAbs). It is estimated to be one of the leading causes of non traumatic neurological disability in young adults...

• Auteur principal: Delgado Varela, Emily Nicole (author)
• Format: bachelorThesis
• Langue: spa
• Publié: 2025
• Sujets: Esclerosis Múltiple; Anticuerpos monoclonales; Perfil de seguridad; Eficacia; Mecanismo de acción; Efectos adversos; Recaídas
• Accès en ligne: http://dspace.unach.edu.ec/handle/51000/15634